Cargando…

Gambogenic acid exerts anticancer effects in cisplatin-resistant non-small cell lung cancer cells

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and the most common cause of mortality in patients with lung cancer. The efficacy of cisplatin-based chemotherapy in NSCLC is limited by drug resistance, therefore, the development of novel anticancer agents is required to ove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Daofu, Wang, Yu, Niu, Hongmei, Liu, Chunying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003042/ https://www.ncbi.nlm.nih.gov/pubmed/31922223 http://dx.doi.org/10.3892/mmr.2020.10909

Ejemplares similares

Gambogenic Acid Kills Lung Cancer Cells through Aberrant Autophagy
por: Mei, Wang, et al.
Publicado: (2014)

Gambogenic Acid Exerts Antitumor Activity in Hypoxic Multiple Myeloma Cells by Regulation of miR-21
por: Liu, Ping, et al.
Publicado: (2017)

Gambogenic acid inhibits the proliferation of small-cell lung cancer cells by arresting the cell cycle and inducing apoptosis
por: Huang, Tingting, et al.
Publicado: (2019)

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin
por: He, Ye, et al.
Publicado: (2015)

Gambogenic acid inhibits fibroblast growth factor receptor signaling pathway in erlotinib-resistant non-small-cell lung cancer and suppresses patient-derived xenograft growth
por: Xu, Linfeng, et al.
Publicado: (2018)

Gambogenic acid synergistically potentiates bortezomib-induced apoptosis in multiple myeloma
por: Chen, Runzhe, et al.
Publicado: (2017)

Gambogenic Acid Induces Endoplasmic Reticulum Stress in Colorectal Cancer via the Aurora A Pathway
por: Liu, Cheng, et al.
Publicado: (2021)

Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction
por: Li, Hecheng, et al.
Publicado: (2009)

Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells
por: Pan, Chun-Hao, et al.
Publicado: (2016)

Pterostilbene exerts anticancer activity on non-small-cell lung cancer via activating endoplasmic reticulum stress
por: Ma, Zhiqiang, et al.
Publicado: (2017)

SKA1 regulates the metastasis and cisplatin resistance of non-small cell lung cancer
por: SHEN, LIHUA, et al.
Publicado: (2016)

Analogs of a Natural Peptaibol Exert Anticancer Activity in Both Cisplatin- and Doxorubicin-Resistant Cells and in Multicellular Tumor Spheroids
por: Casagrande, Naike, et al.
Publicado: (2021)

Cordyceps militaris Exerts Anticancer Effect on Non–Small Cell Lung Cancer by Inhibiting Hedgehog Signaling via Suppression of TCTN3
por: Jo, Eunbi, et al.
Publicado: (2020)

MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
por: Fadejeva, Irina, et al.
Publicado: (2017)

Rosmarinic acid reverses non‐small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway
por: Liao, Xiao‐Zhong, et al.
Publicado: (2020)

EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations
por: Gao, Jing, et al.
Publicado: (2016)

Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
por: Stathopoulos, G. P., et al.
Publicado: (2011)

Gambogic acid and gambogenic acid induce a thiol-dependent heat shock response and disrupt the interaction between HSP90 and HSF1 or HSF2
por: Pesonen, Linda, et al.
Publicado: (2021)

Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer
por: Xiao, Lu, et al.
Publicado: (2017)

Cisplatin in 5% Ethanol Eradicates Cisplatin-Resistant Lung Tumor by Killing Lung Cancer Side Population (SP) Cells and Non-SP Cells
por: Niu, Qi, et al.
Publicado: (2013)

miR-139-5p enhances cisplatin sensitivity in non-small cell lung cancer cells by inhibiting cell proliferation and promoting apoptosis via the targeting of Homeobox protein Hox-B2
por: Du, Hailian, et al.
Publicado: (2021)

Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G(2)/M cell cycle arrest
por: Sarin, Navin, et al.
Publicado: (2017)

Reversal of Cisplatin Resistance with Amphotericin B in a Non‐small Cell Lung Cancer Cell Line
por: Morikage, Toshihiko, et al.
Publicado: (1991)

CDH13 promoter methylation regulates cisplatin resistance of non-small cell lung cancer cells
por: Wang, Yan, et al.
Publicado: (2018)

Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cells
por: Li, Amin, et al.
Publicado: (2020)

CDKN1A upregulation and cisplatin-pemetrexed resistance in non-small cell lung cancer cells
por: Zamagni, Alice, et al.
Publicado: (2020)

Altered Ca-Homeostasis of Cisplatin-Treated and Low Level Resistant Non-Small-Cell and Small-Cell Lung Cancer Cells
por: Schrödl, Kathrin, et al.
Publicado: (2009)

Pharmacogenomics of Cisplatin Sensitivity in Non-small Cell Lung Cancer
por: Rose, Maimon C., et al.
Publicado: (2014)

CUR5g, a novel autophagy inhibitor, exhibits potent synergistic anticancer effects with cisplatin against non-small-cell lung cancer
por: Chen, Jingxuan, et al.
Publicado: (2022)

Acquired differential regulation of caspase-8 in cisplatin-resistant non-small-cell lung cancer
por: Paul, I, et al.
Publicado: (2012)

Increased MALAT1 expression contributes to cisplatin resistance in non-small cell lung cancer
por: Cui, Yong, et al.
Publicado: (2018)

Increased ABCC2 expression predicts cisplatin resistance in non‐small cell lung cancer
por: Chen, Yun, et al.
Publicado: (2020)

A Systems Biology Approach for Addressing Cisplatin Resistance in Non-Small Cell Lung Cancer
por: Ramisetty, Sravani, et al.
Publicado: (2023)

The Combination of RAD001 and NVP-BEZ235 Exerts Synergistic Anticancer Activity against Non-Small Cell Lung Cancer In Vitro and In Vivo
por: Xu, Cheng-Xiong, et al.
Publicado: (2011)

Diethylstilbestrol, a Novel ANO1 Inhibitor, Exerts an Anticancer Effect on Non-Small Cell Lung Cancer via Inhibition of ANO1
por: Seo, Yohan, et al.
Publicado: (2021)

Comparison of Vinorelbine-Cisplatin with Gemcitabine-Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer
por: Ozkaya, Sevket, et al.
Publicado: (2008)

MnTnHex-2-PyP(5+) Displays Anticancer Properties and Enhances Cisplatin Effects in Non-Small Cell Lung Cancer Cells
por: Soares, Rita B., et al.
Publicado: (2022)

Luteolin exerts an anticancer effect on NCI-H460 human non-small cell lung cancer cells through the induction of Sirt1-mediated apoptosis
por: MA, LIPING, et al.
Publicado: (2015)

TRIB2 contributes to cisplatin resistance in small cell lung cancer
por: Liang, Yuanxin, et al.
Publicado: (2017)

MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
por: Li, Weili, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nr4p2nblsf8ul8hhqsfjcffhpt